Last reviewed · How we verify
NCT04192565
A Prospective Investigation of the ColubrisMX ELS System
NA trial testing ColubrisMX Endoluminal Surgical (ELS) System in Colorectal Neoplasms in 10 participants. Completed in 15 April 2021.
15 April 2021
Quick facts
| Lead sponsor | ColubrisMX |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 10 |
| Start date | 13 September 2020 |
| Primary completion | 15 April 2021 |
| Estimated completion | 15 April 2021 |
| Sites | 1 location across Brazil |
Drugs / interventions tested
- ColubrisMX Endoluminal Surgical (ELS) System
Conditions studied
- Colorectal Neoplasms — all drugs for Colorectal Neoplasms →
- Colorectal Polyp — all drugs for Colorectal Polyp →
- Colorectal Adenoma — all drugs for Colorectal Adenoma →
- Colorectal Adenomatous Polyp — all drugs for Colorectal Adenomatous Polyp →
Sponsor
ColubrisMX
Who can join
Adults 18 to 75, any sex, with Colorectal Neoplasms or Colorectal Polyp. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is a prospective, single-arm, open-label, multi-center, feasibility study to evaluate the safety and efficacy of the ColubrisMX ELS System in patients undergoing transanal endoluminal procedures, specifically colorectal Endoscopic Submucosal Dissection.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04192565
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of ColubrisMX Endoluminal Surgical (ELS) System
Trials testing the same drug.
- NCT04651764 — Transanal Resection of Rectal Lesions With the ColubrisMX ELS System · NA · terminated
Other recruiting trials for Colorectal Neoplasms
Currently open trials in the same condition.
- NCT06983639 — Randomized Trial Comparing Fecal Testing (FIT) to Colonoscopy for Post-polypectomy Surveillance · NA · recruiting
- NCT07222800 — Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult · Phase 3 · recruiting
- NCT07239479 — DEXDES Trial: Dexmedetomidine-Desflurane Combination in Laparoscopic Colectomy · NA · recruiting
- NCT07262840 — Health Behavior Change in High-Risk Colorectal Cancer Individuals · NA · recruiting
- NCT07257653 — The Safety and Efficacy of Cetuximab Beta Plus Fruquintinib With or Without Immune Checkpoint Inhibitorrs in First-line · Phase 2 · recruiting
Other ColubrisMX trials
Trials by the same sponsor.
- NCT04651764 — Transanal Resection of Rectal Lesions With the ColubrisMX ELS System · NA · terminated
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04192565 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by ColubrisMX
- Last refreshed: 19 September 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04192565.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing